Homeopathy Persists Despite Lack of Scientific Evidence, Billions Spent Annually

Homeopathy continues to be widely practiced and generate billions in revenue despite a lack of scientific evidence supporting its efficacy, according to recent analyses. The practice, developed in Germany over 200 years ago, is based on two core principles: 'like cures like' (similia similibus curentur) and the 'law of minimum dose,' suggesting extreme dilutions enhance effectiveness. Many homeopathic products are so diluted that they contain no original molecules, essentially consisting of water. Despite this, the U.S. homeopathy market was valued at approximately $4.12 billion in 2025 and is projected to reach $13.38 billion by 2035, growing at a 12.50% CAGR. Some homeopathic products, derived from plants, minerals, or animals, can potentially cause side effects or drug interactions if they contain substantial amounts of active ingredients. Experts emphasize that there is little empirical basis for homeopathy's theories, and its products lack proven curative properties for any specific health condition. The continued popularity and market growth suggest a strong consumer belief in 'natural' remedies, even in the absence of scientific validation. This trend raises concerns among health professionals about patient safety and the diversion of resources from evidence-based medical treatments. The article highlights the significant financial investment in a practice widely considered a scam by critics.

This item matters as it critically examines the persistence of homeopathy despite scientific skepticism, highlighting its significant market size and potential health implications.